# Camp4 Therapeutics Corp: Form SCHEDULE 13D/A, filed Mar 11, 2026

- Company: [Camp4 Therapeutics Corp](/companies/camp.md) (CIK 1736730)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-11
- Accepted by EDGAR: Mar 11, 2026, 17:57 ET
- Period: not reported
- Accession: 0001953107-26-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736730/000195310726000005/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736730/000195310726000005/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736730/000195310726000005/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001953107-26-000005. Last ingested by Listed: Nov 15, 2026, 04:15 ET. No prices; not investment advice.
